Alebund Pharmaceuticals (Jiangsu) Limited (HKG:9637)
Hong Kong · Delayed Price · Currency is HKD 28.80
+0.30 (1.05%)
At close: Sep 4, 2026
HKG:9637 Revenue
Alebund Pharmaceuticals (Jiangsu) had revenue of 52.08M CNY in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to 122.60M. In the year 2025, Alebund Pharmaceuticals (Jiangsu) had annual revenue of 30.56M with 368.29% growth.
Revenue (ttm)
122.60M CNY
Revenue Growth
+368.29%
P/S Ratio
69.15
Revenue / Employee
725.46K CNY
Employees
169
Market Cap
9.79B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 30.56M | 24.03M | 368.29% |
| Dec 31, 2024 | 6.53M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.